Belvedere Trading LLC Moon Lake Immunotherapeutics Put Options Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Nov 01, 2024	BUY	$38.43 - $48.6 $146,034 - $184,680	3,800 New	3,800 $167,000
Q2 2024 Aug 09, 2024	SELL	$38.43 - $48.6 $61,488 - $77,760	-1,600 Reduced 29.63%	3,800 $167,000
Q1 2024 May 09, 2024	SELL	$43.78 - $63.86 $74,426 - $108,562	-1,700 Reduced 23.94%	5,400 $271,000
Q4 2023 Feb 13, 2024	SELL	$36.35 - $63.02 $545,250 - $945,300	-15,000 Reduced 67.87%	7,100 $428,000
Q3 2023 Oct 27, 2023	BUY	$48.35 - $61.26 $1.07 Million - $1.35 Million	22,100 New	22,100 $1.26 Million

131

58.4M

77.2K

63K

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $1.61B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.